Sfoglia per Autore
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience
2019-01-01 D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F.
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
2019-01-01 D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco
Pharmacoeconomics of synthetic therapies for multiple sclerosis
2019-01-01 D’Amico, E.; Chisari, C. G.; Gitto, L.; Zanghì, A.; Toscano, S.; Patti, F.
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives
2019-01-01 D'Amico, E; Zanghì, A; Gastaldi, M; Patti, F; Zappia, M; Franciotta, D
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
2019-01-01 D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Fermo, Salvatore Lo; Toscano, Simona; Arena, Sebastiano; Patti, Francesco; Zappia, Mario
An update on the safety of treating relapsing-remitting multiple sclerosis
2019-01-01 Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
2020-01-01 Zanghì, Aurora; D'Amico, Emanuele; Callari, Graziella; Chisari, Clara Grazia; Borriello, Giovanna; Grimaldi, Luigi Maria Edoardo; Patti, Francesco
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment
2020-01-01 Zanghi, A.; D'Amico, E.; Patti, F.
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
2020-01-01 Zanghì, Aurora; D'Amico, Emanuele; Luca, Maria; Ciaorella, Marco; Basile, Lucia; Patti, Francesco
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis
2020-01-01 D'Amico, E.; Zanghi, A.; Sciandra, M.; Lanzillo, R.; Callari, G.; Cortese, A.; Lus, G.; Lucchini, M.; Buccafusca, M.; Bonavita, S.; Gallo, A.; Curti, E.; Gajofatto, A.; Signoriello, E.; Bisecco, A.; Gobbin, F.; Ferro, M. T.; Ferrazzano, G.; Sparaco, M.; Valentino, P.; Mirabella, M.; Granella, F.; Bresciamorra, V.; Grimaldi, L. M. E.; Patti, F.; Borriello, G.; Grossi, P.; Carotenuto, A.; Siena, E.; Tsantes, E.; Abbadessa, G. M.; Chisari, C. G.
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients
2020-01-01 Zanghi, A.; Cimino, S.; Urzi, D.; Privitera, S.; Zagari, F.; Lanza, G.; Patti, F.; D'Amico, E.
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
2020-01-01 D'Amico, Emanuele; Zanghì, Aurora; Burgio, Giovanni; Chisari, Clara Grazia; Condorelli, Rosita Angela; La Vignera, Sandro; Calogero, Aldo Eugenio; Patti, Francesco
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control study
2021-01-01 D'Amico, Emanuele; Zanghi', Aurora; Calogero, Aldo Eugenio; Patti, Francesco
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
2021-01-01 D'Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo
Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis
2021-01-01 D’Amico, Emanuele; Grosso, Giuseppe; Nieves, Jeri W.; Zanghi', Aurora; Factor-Litvak, Pam; Mitsumoto, Hiroshi
Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
2021-01-01 Zanghi, A.; D'Amico, E.; Lo Fermo, S.; Patti, F.
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study
2021-01-01 Zanghì, A; Avolio, C; Amato, Mp; Filippi, M; Trojano, M; Patti, F; D'Amico, E; Italian MS registry, Study.; D'Amico, Emanuele
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
2021-01-01 Zanghì, A; Gallo, A; Avolio, C; Capuano, R; Lucchini, M; Petracca, M; Bonavita, S; Lanzillo, R; Ferraro, D; Curti, E; Buccafusca, M; Callari, G; Barone, S; Pontillo, G; Abbadessa, G; Di Francescantonio, V; Signoriello, E; Lus, G; Sola, P; Granella, F; Valentino, P; Mirabella, M; Patti, F; D'Amico, E.; D'Amico, Emanuele
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
2021-01-01 D'Amico, E.; Zanghi, A.; Romeo, M.; Cocco, E.; Maniscalco, G. T.; Brescia Morra, V.; Paolicelli, D.; De Luca, G.; Galgani, S.; Amato, M. P.; Salemi, G.; Inglese, M.; Confalonieri, P. A.; Lus, G.; Avolio, C.; Gallo, A.; Vianello, M.; Onofrj, M.; Filippi, M.; Trojano, M.; Patti, F.
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS
2022-01-01 D’Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo; Hartung, Hans-Peter
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience | 1-gen-2019 | D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F. | |
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort | 1-gen-2019 | D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco | |
Pharmacoeconomics of synthetic therapies for multiple sclerosis | 1-gen-2019 | D’Amico, E.; Chisari, C. G.; Gitto, L.; Zanghì, A.; Toscano, S.; Patti, F. | |
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives | 1-gen-2019 | D'Amico, E; Zanghì, A; Gastaldi, M; Patti, F; Zappia, M; Franciotta, D | |
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience | 1-gen-2019 | D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Fermo, Salvatore Lo; Toscano, Simona; Arena, Sebastiano; Patti, Francesco; Zappia, Mario | |
An update on the safety of treating relapsing-remitting multiple sclerosis | 1-gen-2019 | Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco | |
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience | 1-gen-2020 | Zanghì, Aurora; D'Amico, Emanuele; Callari, Graziella; Chisari, Clara Grazia; Borriello, Giovanna; Grimaldi, Luigi Maria Edoardo; Patti, Francesco | |
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment | 1-gen-2020 | Zanghi, A.; D'Amico, E.; Patti, F. | |
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience | 1-gen-2020 | Zanghì, Aurora; D'Amico, Emanuele; Luca, Maria; Ciaorella, Marco; Basile, Lucia; Patti, Francesco | |
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis | 1-gen-2020 | D'Amico, E.; Zanghi, A.; Sciandra, M.; Lanzillo, R.; Callari, G.; Cortese, A.; Lus, G.; Lucchini, M.; Buccafusca, M.; Bonavita, S.; Gallo, A.; Curti, E.; Gajofatto, A.; Signoriello, E.; Bisecco, A.; Gobbin, F.; Ferro, M. T.; Ferrazzano, G.; Sparaco, M.; Valentino, P.; Mirabella, M.; Granella, F.; Bresciamorra, V.; Grimaldi, L. M. E.; Patti, F.; Borriello, G.; Grossi, P.; Carotenuto, A.; Siena, E.; Tsantes, E.; Abbadessa, G. M.; Chisari, C. G. | |
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients | 1-gen-2020 | Zanghi, A.; Cimino, S.; Urzi, D.; Privitera, S.; Zagari, F.; Lanza, G.; Patti, F.; D'Amico, E. | |
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study | 1-gen-2020 | D'Amico, Emanuele; Zanghì, Aurora; Burgio, Giovanni; Chisari, Clara Grazia; Condorelli, Rosita Angela; La Vignera, Sandro; Calogero, Aldo Eugenio; Patti, Francesco | |
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control study | 1-gen-2021 | D'Amico, Emanuele; Zanghi', Aurora; Calogero, Aldo Eugenio; Patti, Francesco | |
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies | 1-gen-2021 | D'Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo | |
Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis | 1-gen-2021 | D’Amico, Emanuele; Grosso, Giuseppe; Nieves, Jeri W.; Zanghi', Aurora; Factor-Litvak, Pam; Mitsumoto, Hiroshi | |
Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study | 1-gen-2021 | Zanghi, A.; D'Amico, E.; Lo Fermo, S.; Patti, F. | |
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study | 1-gen-2021 | Zanghì, A; Avolio, C; Amato, Mp; Filippi, M; Trojano, M; Patti, F; D'Amico, E; Italian MS registry, Study.; D'Amico, Emanuele | |
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study | 1-gen-2021 | Zanghì, A; Gallo, A; Avolio, C; Capuano, R; Lucchini, M; Petracca, M; Bonavita, S; Lanzillo, R; Ferraro, D; Curti, E; Buccafusca, M; Callari, G; Barone, S; Pontillo, G; Abbadessa, G; Di Francescantonio, V; Signoriello, E; Lus, G; Sola, P; Granella, F; Valentino, P; Mirabella, M; Patti, F; D'Amico, E.; D'Amico, Emanuele | |
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register | 1-gen-2021 | D'Amico, E.; Zanghi, A.; Romeo, M.; Cocco, E.; Maniscalco, G. T.; Brescia Morra, V.; Paolicelli, D.; De Luca, G.; Galgani, S.; Amato, M. P.; Salemi, G.; Inglese, M.; Confalonieri, P. A.; Lus, G.; Avolio, C.; Gallo, A.; Vianello, M.; Onofrj, M.; Filippi, M.; Trojano, M.; Patti, F. | |
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS | 1-gen-2022 | D’Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo; Hartung, Hans-Peter |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile